wegovy glp-1 May Carry Highest Risk of Blinding Condition Among Drugs POTD: Wegovy and Ozempic —

Non-Surgical Approach: For those looking for a less invasive option, GLP-1 therapy provides a way to achieve results without undergoing a surgical procedure

Studies have shown that people on these medications may eat up to 3040% fewer calories than before

The latest data also shows that most people stop taking GLP-1s within 12 months and experience significant side effects throughout treatment

Presented at: 43rd Miami Breast Cancer Conference

Orexin is definitely another molecule that is all the rage right now because were seeing the development of orexin agonists and how they may be potentially meaningful in the treatment of narcolepsy

Another meta-analysis conducted on adolescents with overweight/obesity without T2D reported that GLP-1RAs had a better anti-obesity effect when compared to placebo or lifestyle modification (semaglutide is better than liraglutide and exenatide for weight control) [35]